{"id":"https://openalex.org/W2444338944","doi":null,"title":"Protection of normal tissues from radiation and cytotoxic therapy: the development of amifostine.","display_name":"Protection of normal tissues from radiation and cytotoxic therapy: the development of amifostine.","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2444338944","mag":"2444338944","pmid":"https://pubmed.ncbi.nlm.nih.gov/10363072"},"language":"en","primary_location":{"id":"pmid:10363072","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10363072","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2444338944"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033486739","display_name":"Fabiana Castiglione","orcid":"https://orcid.org/0000-0002-1099-442X","observed_orcids":["https://orcid.org/0000-0002-1099-442X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Castiglione","raw_affiliation_strings":["Service of Medical Oncology, Civic Hospital, Alba, Italy. castiglione@dada.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service of Medical Oncology, Civic Hospital, Alba, Italy. castiglione@dada.it","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001371273","display_name":"Annarita Mola","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Dalla Mola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5005305678","display_name":"Gianfranco Porcile","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G Porcile","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.6642,"has_fulltext":false,"cited_by_count":35,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.87692717,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"85","issue":"2","first_page":"85","last_page":"91"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11359","display_name":"Effects of Radiation Exposure","score":0.009700000286102295,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amifostine","display_name":"amifostine","score":1.0},{"id":"https://openalex.org/keywords/cytoprotection","display_name":"cytoprotection","score":0.9520000219345093},{"id":"https://openalex.org/keywords/normal-tissue-toxicity","display_name":"normal tissue toxicity","score":0.6830000281333923},{"id":"https://openalex.org/keywords/radiotherapy","display_name":"radiotherapy","score":0.4569999873638153},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.6330000162124634},{"id":"https://openalex.org/keywords/cisplatin-induced-nephrotoxicity","display_name":"cisplatin nephrotoxicity","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cisplatin-neurotoxicity","display_name":"cisplatin neurotoxicity","score":0.8939999938011169},{"id":"https://openalex.org/keywords/alkylating-agents","display_name":"alkylating agents","score":0.9449999928474426},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.9940000176429749},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6710000038146973},{"id":"https://openalex.org/keywords/hypotension","display_name":"hypotension","score":0.6370000243186951},{"id":"https://openalex.org/keywords/cost-benefit-analysis","display_name":"cost-benefit analysis","score":0.9670000076293945}],"concepts":[{"id":"https://openalex.org/C2779387952","wikidata":"https://www.wikidata.org/wiki/Q251698","display_name":"Amifostine","level":3,"score":0.9919304847717285},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7298969030380249},{"id":"https://openalex.org/C2780967304","wikidata":"https://www.wikidata.org/wiki/Q246156","display_name":"Cytoprotection","level":3,"score":0.5605294108390808},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.5367885828018188},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5196889042854309},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4870813190937042},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.47413942217826843},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4167623519897461},{"id":"https://openalex.org/C3454156","wikidata":"https://www.wikidata.org/wiki/Q1144241","display_name":"Side effect (computer science)","level":2,"score":0.41498151421546936},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2520286440849304},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.16692271828651428},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004999","descriptor_name":"Amifostine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004999","descriptor_name":"Amifostine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011837","descriptor_name":"Radiation-Protective Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011837","descriptor_name":"Radiation-Protective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011878","descriptor_name":"Radiotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10363072","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10363072","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tumori","raw_type":"Journal Article"},{"id":"mag:2444338944","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10363072","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2023645569","https://openalex.org/W2020445874","https://openalex.org/W2429375881","https://openalex.org/W2055974418","https://openalex.org/W4254408206","https://openalex.org/W2044972421","https://openalex.org/W2411116546","https://openalex.org/W2416951843","https://openalex.org/W2524843590","https://openalex.org/W2076652907"],"abstract_inverted_index":{"Much":[0],"effort":[1],"is":[2,32,42,108,116,124,129,141],"being":[3],"made":[4],"to":[5,15,78,93],"reduce":[6],"the":[7,17,35,43,49,53,143,165],"iatrogenic":[8],"toxicity":[9,69],"of":[10,19,21,25,34,39,62,97,106,145],"antineoplastic":[11],"treatments":[12],"in":[13,48,70,112],"order":[14],"improve":[16],"quality":[18],"life":[20],"cancer":[22],"patients.":[23],"Cytoprotection":[24,126],"healthy":[26,100],"tissue":[27],"by":[28,127],"thiol":[29],"group":[30],"donors":[31],"one":[33],"most":[36,44,166],"promising":[37,167],"lines":[38],"research.":[40],"Amifostine":[41],"extensively":[45],"studied":[46],"drug":[47],"category.":[50],"We":[51],"reviewed":[52],"extensive":[54],"medical":[55],"literature":[56],"on":[57,99,164],"amifostine.":[58],"The":[59,152],"protective":[60,84],"effect":[61,85,105],"amifostine":[63,98,107,128],"has":[64,86],"been":[65,87],"demonstrated":[66],"for":[67,89,133,147],"cisplatin-induced":[68],"lung":[71],"and":[72,81,136,160],"ovarian":[73],"cancer,":[74],"with":[75],"particular":[76],"regard":[77],"nephrotoxicity,":[79],"neurotoxicity":[80],"neutropenia.":[82],"No":[83],"seen":[88],"tumor":[90],"cells":[91],"owing":[92],"a":[94,109,157,161],"selective":[95],"action":[96],"tissues.":[101],"A":[102],"frequent":[103],"side":[104],"transient":[110],"decreases":[111],"blood":[113],"pressure;":[114],"it":[115,140],"usually":[117],"asymptomatic":[118],"if":[119],"an":[120],"easily":[121],"handled":[122],"premedication":[123],"given.":[125],"also":[130,155],"well":[131],"known":[132],"alkylating":[134],"drugs":[135],"radiation":[137],"therapy,":[138],"whereas":[139],"still":[142],"object":[144],"study":[146],"new":[148],"drugs,":[149],"especially":[150],"taxanes.":[151],"present":[153],"work":[154],"includes":[156],"cost-benefit":[158],"analysis":[159],"prospective":[162],"view":[163],"research":[168],"lines.":[169]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2444338944","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
